Graham Capital Management, L.P. Royalty Pharma PLC Transaction History

Graham Capital Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$26.21 - $29.22 $523,282 - $583,377	-19,965 Reduced 69.29%	8,847 $248,000
Q3 2023 Nov 22, 2023	SELL	$26.26 - $31.38 $2.18 Million - $2.6 Million	-82,994 Reduced 74.23%	28,812 $781,000
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $2.84 Million - $3.51 Million	96,014 Added 607.99%	111,806 $3.44 Million
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $1.81 Million - $2.18 Million	-55,279 Reduced 77.78%	15,792 $568,000
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $2.15 Million - $2.42 Million	54,917 Added 339.96%	71,071 $2.81 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $644,221 - $721,276	16,154 New	16,154 $649,000
Q2 2022 Aug 15, 2022	SELL	$37.53 - $44.22 $1.67 Million - $1.97 Million	-44,459 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $1.47 Million - $1.66 Million	39,142 Added 736.17%	44,459 $1.73 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $186,998 - $225,866	5,317 New	5,317 $211,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.